Alphadyne Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,940
Closed -$848K 862
2026
Q1
$857K Buy
+3,940
New +$874K 0.01% 599
2023
Q4
Sell
-10,459
Closed -$1.56M 30
2023
Q3
$1.56M Buy
10,459
+4,960
+90% +$728K 0.12% 123
2023
Q2
$741K Buy
+5,499
New +$806K 0.09% 71

Other funds holding ABBV

Alphadyne Asset Management's ABBV Position: Q2 2026 in Review

Alphadyne Asset Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 3,940 shares — an estimated $848K sold.

Alphadyne Asset Management first reported a position in ABBV in Q2 2023 and held it in 3 quarters. The position peaked at $1.56M in Q3 2023. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Alphadyne Asset Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Alphadyne Asset Management sold 3,940 AbbVie shares in Q2 2026, an estimated $848K.
  • Alphadyne Asset Management first reported a position in AbbVie in Q2 2023 and held it in 3 quarters.
  • Alphadyne Asset Management's AbbVie position peaked at $1.56M in Q3 2023.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.